未登录

J

Jason M. Vanatta

national institutes of health (nih) - usa

H指数:16

被引数:952

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-modal machine learning highlights recipient genetic and clinical factors as primary drivers of post-transplant MASLD: A two-center study

多模态机器学习揭示受者遗传和临床因素是移植后MASLD的主要驱动因素：一项两中心研究

Liver Transplantation

IF3.9

2026-04-010

PRE

Skin Closure Technique Matters: Fewer Wound Infections After Kidney Transplant in Patients With Class 2 Obesity Using Subcuticular Sutures

CLINICAL TRANSPLANTATION

IF1.9

2025-11-050

PRE

Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH Consortium

TRANSPLANTATION

IF5

2024-10-220

PRE

Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCR

FRONTIERS IN MEDICINE

IF3

2024-04-100

OAAI

Automated Segmentation and Morphological Characterization of Hepatic Steatosis and Correlation with Histopathology

clinical and experimental pediatrics

IF3.2

2023-05-013

OAAI

Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2023-02-0116

PRE

Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience

IF15.8

2020-04-1595

PREAI

Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2020-02-0144

OAAI

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy

将HCV病毒型肝脏移植到HCV病毒型受体中，然后进行直接抗病毒治疗

clinical and translational gastroenterology

IF4.2

2019-06-047

OAAI

Achieving Sustained Virological Response in Liver Transplant Recipients With Hepatitis C Decreases Risk of Decline in Renal Function

LIVER TRANSPLANTATION

IF3.9

2018-08-246

PREAI

The combination of acute-on-chronic liver failure (ACLF) as defined by EASL-CLIF consortiumdefinition and MELD can predict post-transplant survival in patients with ACLF

JOURNAL OF HEPATOLOGY

IF33

2018-04-010

PREAI

Chimney Patch Balloon Occlusion Technique for Transplantation to Heavily Calcified Vessels

JOURNAL OF VASCULAR SURGERY

IF3.6

2017-08-010

OAAI

Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors

TRANSPLANTATION

IF5

2017-04-0148

OAAI

Sorafenib therapy in orthotopic liver transplant recipients with hepatocellular carcinoma beyond Milan criteria on explant

JOURNAL OF HEPATOLOGY

IF33

2017-01-011

PREAI

Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients

TRANSPLANTATION

IF5

2015-06-0118

OAAI

Magnetic Resonance Cholangio-Pancreatography (MRCP) Has Low Sensitivity in Diagnosing Biliary Strictures After Liver Transplantation: a Single Tertiary Care Center Experience

GASTROINTESTINAL ENDOSCOPY

IF7.5

2015-05-010

PREAI

A Clinical Algorithm to Guide the Need for ERCP for Evaluation of Early Post Liver Transplant Cholestasis

TRANSPLANTATION

IF5

2014-07-011

PREAI

The Effect of Red Blood Cell Transfusion and Red Blood Cell Age On Short Term Survival in Liver Transplantation.

TRANSPLANTATION

IF5

2014-07-010

OAAI

Long Term Outcomes of Early Compared To Late Onset Choledocho-Choledochal Anastomotic Stenosis After Orthotopic Liver Transplantation.

TRANSPLANTATION

IF5

2014-07-010

OAAI

Conventional Bicaval Adult Liver Transplantation Without VenoVenous Bypass Carries a Low Risk of Intraoperative Cardiac Arrest and Mortality

TRANSPLANTATION

IF5

2014-07-010

PREAI